Travere Therapeutics, Inc.
USD57.05
-1.25 (-2.14%)
CEO
Eric Dube
IPO Date
2012-11-08
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$58.61
Prev. Close
$58.30
Day Low
$56.74
Day High
$58.73
52W Low
$14.36
52W High
$60.10
Market Cap
$5.31B
Volume
1.41M
| -4.3 |
| 31 Dec 2023 | FY | 92.1% | -76.7% | -55.5% | -14.1% | 2.02 | 3.47 | -6.0 |
| 31 Dec 2022 | FY | 96.0% | -254.4% | -649.9% | -41.4% | 9.51 | 3.42 | -4.8 |
| 31 Dec 2021 | FY | 97.1% | -136.6% | -59.6% | -23.2% | 0.87 | 4.70 | -10.3 |
| 31 Dec 2020 | FY | 96.9% | -85.4% | -80.2% | -27.9% | 1.16 | 4.43 | -7.6 |
| 31 Dec 2019 | FY | 97.0% | -83.5% | -66.2% | -24.2% | 0.97 | 4.50 | -4.1 |
| 31 Dec 2018 | FY | 96.6% | -62.5% | -32.3% | -14.5% | 0.68 | 4.74 | -8.9 |
| 31 Dec 2017 | FY | 97.7% | -38.6% | -20.4% | -11.5% | 0.15 | 3.80 | -13.7 |
| 31 Dec 2016 | FY | 96.6% | -35.9% | -15.6% | -9.1% | 0.14 | 3.99 | -14.6 |
| 316.1 |
| 30 Sept 2025 | Q3 | 99.0% | 15.6% | 34.9% | 4.8% | 4.48 | 2.75 | 20.7 |
| 30 Jun 2025 | Q2 | 98.7% | -11.1% | -39.0% | -2.3% | 12.20 | 2.00 | -25.8 |
| 31 Mar 2025 | Q1 | 94.3% | -50.4% | -125.6% | -7.5% | 12.20 | 2.05 | -9.6 |
| 31 Dec 2024 | Q4 | 96.6% | -80.6% | -102.0% | -10.1% | 6.80 | 2.08 | -6.0 |
| 30 Sept 2024 | Q3 | 97.4% | -87.1% | 180.0% | -10.9% | -13.21 | 1.71 | -5.0 |
| 30 Jun 2024 | Q2 | 77.1% | -130.1% | -464.8% | -12.8% | 26.62 | 3.04 | -2.3 |
| 31 Mar 2024 | Q1 | 96.4% | -328.9% | -183.7% | -20.5% | 5.45 | 2.78 | -1.0 |
| 31 Dec 2023 | Q4 | 63.6% | -200.1% | -44.9% | -11.4% | 2.02 | 3.47 | -1.9 |